FDA sidewinder hits Caraco, Sun Pharma suffers collateral damage

Caraco Pharmaceutical Laboratories, a 74% subsidiary of Sun Pharmaceutical Industries, has come under fire from the FDA. American enforcement officials raided Caraco’s plants, seized medicines and ingredients used in their production. The seizure has been attributed to Caraco’s continued failure to meet cGMP norms (current good manufacturing practices). The FDA had warned Caraco in October 2008 and had given it time to rectify the deficiencies.

Continue Reading

Nandan Nilekani leaves Infosys, joins government

 Nandan Nilekani is leaving Infosys as its co-chairman to join the government. He has the task of handing out a unique identification card to every citizen of this country. It’s a simple enough task by itself; but made complex by a large population, spread across a vast geography and the failure of such schemes in the past. Nearly a decade ago, the election commission’s voter identity card programme is still to cover vast parts of the population. Mr Nilekani’s challenge will be to do much better.

Continue Reading

Opto Circuits joins the long list of companies lining up to raise money.

Opto Circuits India has taken enabling approval from its board of directors for raising Rs 400 crore under a qualified institutional placement. The company, which makes medical equipment and electronic components, has also taken approval for an issue of warrants to its promoters. It can issue 60 lakh equity warrants to promoters, directors and employees on a preferential basis. Each warrant will fetch one equity share at a price of Rs 210 compared to the current price of Rs 186. Promoters are in a rush to get warrant issues approved.

Continue Reading

Anand Mahindra no longer a promoter of Kotak Mahindra Bank

Anand Mahindra, vice-chairman and managing director of Kotak Mahindra Bank has told the bank that he does not wish to continue as the promoter of the bank. The board has also approved his request to cease as a promoter. He will continue to be on the board as a non-executive director. Normally, one would wonder why this happened. But in this case, Kotak Mahindra Bank has said that Mr Mahindra’s stake –3.68% including entities controlled by him- will now be reclassified as non-promoter holding.

Continue Reading

Siemens to expand steam turbine plant capacity

The company was making single stage and multi stage steam turbines with a capacity of up to 45mw for industrial applications. Steam turbines can be used for various purposes, as a pump drive (feedwater pumps for large boilers), generator drive, compressor drive and waste to energy applications (source: www.siemens.com). The Vadodara factory was set up with an initial investment of Rs 30 crore and after this expansion will be able to make turbines with a capacity of up to 100mw.

Continue Reading

Novartis revises open offer price by 28% to Rs 450

Novartis AG has offered Novartis India’s shareholders Rs 99 more per share to make its open offer more attractive. The promoter holding in Novartis will increase to 89.93%, if the offer succeeds, just below the 90% cap on promoter holding in a listed company. The current share price is Rs 444 and it remains to be seen how many shareholders tender, even at the revised price of Rs 450. The price had touched a high of Rs 467 indicating investors were expecting the revised price to be higher.

Continue Reading